Tilray | TRLY - Ebitda





Ebitda Cambiamento Data
Acasti Pharma USD -3.01M 562K 2026-03
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Aurora Cannabis CAD 799K 2.9M 2026-06
Avita Medical AUD -5.56M 4.13M 2026-06
Canopy Growth CAD 8M 145M 2026-06
Cronos Group USD -1.41M 1.86M 2026-03
Dianthus Therapeutics USD -61.38M 14.92M 2026-06
Divis Laboratories Ltd INR 12.62B 3.28B 2026-06
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
IQVIA Holdings USD 1.03B 38M 2026-09
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Moderna USD -1.26B 468M 2026-03
Organigram Holdings CAD 15.45M 20.21M 2026-06
Organon & Co USD 502M 131M 2026-09
Revvity USD 228.18M 44.73M 2026-06
Tectonic Therapeutic USD -21.18M 365K 2025-12
Tilray USD 8.36M 1.82M 2025-09
Viatris USD 1.19B 138.8M 2026-06
Xeris Pharmaceuticals USD -20.94M 33.27M 2026-06
Zealand Pharma A/S -379M 348.47M 2026-03